| 6101 |
Bone Marrow |
Allogeneic |
Diffuse Large B-Cell Lymphoma |
Hematology |
2018 |
Standard Therapy |
Poland |
68 |
| 6102 |
Bone Marrow |
Allogeneic |
Fanconi Anemia |
Hematology |
2018 |
Standard Therapy |
Poland |
3 |
| 6103 |
Bone Marrow |
Allogeneic |
Fanconi Anemia |
Hematology |
2018 |
Standard Therapy |
Poland |
3 |
| 6104 |
Bone Marrow |
Allogeneic |
Hodgkin Lymphoma |
Hematology |
2018 |
Standard Therapy |
Poland |
31 |
| 6105 |
Bone Marrow |
Allogeneic |
Hurler Syndrome |
Hematology |
2018 |
Standard Therapy |
Poland |
2 |
| 6106 |
Bone Marrow |
Allogeneic |
Juvenile Myelomonocytic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
11 |
| 6107 |
Bone Marrow |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2018 |
Standard Therapy |
Poland |
4 |
| 6108 |
Bone Marrow |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2018 |
Standard Therapy |
Poland |
12 |
| 6109 |
Bone Marrow |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2018 |
Standard Therapy |
Poland |
2 |
| 6110 |
Bone Marrow |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2018 |
Standard Therapy |
Poland |
70 |
| 6111 |
Bone Marrow |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2018 |
Standard Therapy |
Poland |
4 |
| 6112 |
Bone Marrow |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2018 |
Standard Therapy |
Poland |
4 |
| 6113 |
Bone Marrow |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2018 |
Standard Therapy |
Poland |
31 |
| 6114 |
Bone Marrow |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2018 |
Standard Therapy |
Poland |
37 |
| 6115 |
Bone Marrow |
Allogeneic |
No Data |
Hematology |
2018 |
Standard Therapy |
Poland |
16 |
| 6116 |
Bone Marrow |
Allogeneic |
No Data |
Hematology |
2018 |
Standard Therapy |
Poland |
48 |
| 6117 |
Bone Marrow |
Allogeneic |
No Data |
Hematology |
2018 |
Standard Therapy |
Poland |
52 |
| 6118 |
Bone Marrow |
Allogeneic |
No Data |
Hematology |
2018 |
Standard Therapy |
Poland |
1 |
| 6119 |
Bone Marrow |
Allogeneic |
No Data |
Hematology |
2018 |
Standard Therapy |
Poland |
1 |
| 6120 |
Bone Marrow |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2018 |
Standard Therapy |
Poland |
62 |
| 6121 |
Bone Marrow |
Allogeneic |
Other Non-Malignant Disease |
Hematology |
2018 |
Standard Therapy |
Poland |
29 |
| 6122 |
Bone Marrow |
Allogeneic |
Primary Myelofibrosis Grade III |
Hematology |
2018 |
Standard Therapy |
Germany |
73 |
| 6123 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2018 |
Standard Therapy |
Poland |
19 |
| 6124 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2018 |
Standard Therapy |
Poland |
14 |
| 6125 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2018 |
Standard Therapy |
Poland |
27 |
| 6126 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2018 |
Standard Therapy |
Poland |
18 |
| 6127 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2018 |
Standard Therapy |
Poland |
2 |
| 6128 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2018 |
Standard Therapy |
Poland |
20 |
| 6129 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2018 |
Standard Therapy |
Poland |
6 |
| 6130 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2018 |
Standard Therapy |
Germany |
54 |
| 6131 |
Bone Marrow |
Allogeneic |
Severe Combined Immunodeficiency |
Hematology |
2018 |
Standard Therapy |
Poland |
2 |
| 6132 |
Bone Marrow |
Allogeneic |
Severe Combined Immunodeficiency |
Hematology |
2018 |
Standard Therapy |
Poland |
1 |
| 6133 |
Bone Marrow |
Allogeneic |
Severe Combined Immunodeficiency |
Hematology |
2018 |
Standard Therapy |
Poland |
7 months |
| 6134 |
Bone Marrow |
Allogeneic |
Severe Combined Immunodeficiency |
Hematology |
2018 |
Standard Therapy |
Poland |
21 |
| 6135 |
Bone Marrow |
Allogeneic |
T-Cell Leukemia/Lymphoma |
Hematology |
2018 |
Standard Therapy |
Poland |
10 |
| 6136 |
Bone Marrow |
Allogeneic |
Thalassemia Major |
Hematology |
2018 |
Standard Therapy |
Poland |
14 |
| 6137 |
Bone Marrow |
Allogeneic |
Thalassemia Major |
Hematology |
2018 |
Standard Therapy |
Poland |
12 |
| 6138 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
29 |
| 6139 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
63 |
| 6140 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
65 |
| 6141 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
48 |
| 6142 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
50 |
| 6143 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
33 |
| 6144 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
61 |
| 6145 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
42 |
| 6146 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
47 |
| 6147 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
62 |
| 6148 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
50 |
| 6149 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
8 |
| 6150 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
49 |
| 6151 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
59 |
| 6152 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
20 |
| 6153 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
27 |
| 6154 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
1 |
| 6155 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
61 |
| 6156 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
33 |
| 6157 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
33 |
| 6158 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
21 |
| 6159 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
39 |
| 6160 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
50 |
| 6161 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
7 months |
| 6162 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
25 |
| 6163 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
64 |
| 6164 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
36 |
| 6165 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
49 |
| 6166 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
20 |
| 6167 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
44 |
| 6168 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
59 |
| 6169 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
55 |
| 6170 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
30 |
| 6171 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
34 |
| 6172 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
48 |
| 6173 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
40 |
| 6174 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
45 |
| 6175 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
9 |
| 6176 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
8 |
| 6177 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
47 |
| 6178 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
24 |
| 6179 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Germany |
52 |
| 6180 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Germany |
43 |
| 6181 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Germany |
52 |
| 6182 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Germany |
59 |
| 6183 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Germany |
24 |
| 6184 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
26 |
| 6185 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
35 |
| 6186 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
59 |
| 6187 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
42 |
| 6188 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
46 |
| 6189 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
66 |
| 6190 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
46 |
| 6191 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
34 |
| 6192 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
72 |
| 6193 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
45 |
| 6194 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
45 |
| 6195 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
67 |
| 6196 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
30 |
| 6197 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
71 |
| 6198 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
56 |
| 6199 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
61 |
| 6200 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
51 |